XSTO
ARJO B
Market cap745mUSD
Jul 22, Last price
26.52SEK
1D
-0.15%
1Q
4.99%
IPO
8.91%
Name
Arjo AB (publ)
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Arjo AB (publ), a company established in 1957 and based in Malmö, Sweden, specializes in developing and marketing healthcare technologies and services. The firm focuses on aiding individuals facing reduced mobility and age-related health issues, with operations spanning North America, Western Europe, and various other international regions. Their comprehensive product line encompasses equipment for patient handling, sanitation, disinfection, and medical beds. Additionally, Arjo provides advanced solutions for the prevention and treatment of pressure injuries, leg ulcers, deep vein thrombosis, and edema, alongside diagnostic tools for obstetric and cardiac care. Complementing their product offerings, the company delivers specialized room assessment services for dementia and bariatric patients, clinical advisory, maintenance support, and flexible equipment rental and financing plans. Arjo's clientele primarily consists of private and public healthcare facilities offering both acute and long-term care.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||